F. Berner

Type de document

Articles (4)

Co-auteur

Date

Source

Mot-clé

thérapie (4) Treatment (4) Inhibitors (4) Therapeutics (4) Patients (4) Human beings (4) Patients (4) survie (3) Development (3) Survival (3) Melanoma (3) Cancer (3) Older people (3) Use (3) différenciation (2) biomarqueur (2) Differentiation (2) Tumors (2) T cells (2) Serum (2) Proteins (2) Organ (Musical instrument) (2) Lymphocytes (2) Lungs--Cancer (2) Lungs (2) Cancer--Patients (2) Biochemical markers (2) Antigens (2) Tumors (2) Organs (2)

Documents écrit par F. Berner (4) | parle de F. Berner (0)

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
M.T. Purde et al.
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.
O. Hasan Ali et al.
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
F. Berner et al. (2021)
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.
M. Fässler et al. (20 févr. 2019)